Skip to content

Insider · CIK 0002092424

Khing Djien Oei

director

Files at CYPH (LEAP THERAPEUTICS, INC.). First filing Sep 25, 2026, latest Sep 25, 2026.

In brief

Khing Djien Oei files SEC Form 4 as director at CYPH (LEAP THERAPEUTICS, INC.). Since Sep 25, 2026, Khing Djien Oei has reported 0 open-market buys worth $0 and 1 open-market sell worth $662k, the latest filed on Sep 25, 2026.

A track record needs three past buys with six months of prices behind them; Khing Djien Oei has 0, so none is measured yet.

The newest scored trade: sold $662k of CYPH on Sep 25, 2026, filed Sep 25, 2026, scored 63 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $662k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $662k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CYPH: LEAP THERAPEUTICS, INC.

CYPHOct 12, 2026 · close 2.90

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
63Notable
CYPHsell 2
LEAP THERAPEUTICS, INC.
$662k
168,750 shares
-100%-

Transactions

Every row this insider has filed, 11 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 25, 2026CYPH
LEAP THERAPEUTICS, INC.
SOpen-market sale
Common Stock
-168,750$3.92$662k019 d ago
Jul 1, 2026CYPH
LEAP THERAPEUTICS, INC.
AGrant or award
Restricted Stock Unitsderivative
-100,000$0.00$0100,000Jul 2, 2026
Mar 13, 2026CYPH
LEAP THERAPEUTICS, INC.
MOption exercise
Common Stock
+74,700--74,700Mar 17, 2026
Mar 13, 2026CYPH
LEAP THERAPEUTICS, INC.
MOption exercise
Common Stock
+94,050--168,750Mar 17, 2026
Mar 13, 2026CYPH
LEAP THERAPEUTICS, INC.
MOption exercise
Restricted Stock Unitsderivative
-74,700$0.00$00Mar 17, 2026
Mar 13, 2026CYPH
LEAP THERAPEUTICS, INC.
MOption exercise
Restricted Stock Unitsderivative
-94,050$0.00$00Mar 17, 2026
Dec 23, 2025CYPH
LEAP THERAPEUTICS, INC.
AGrant or award
Restricted Stock Unitsderivative
+94,050$0.00$094,050Dec 30, 2025
Dec 23, 2025CYPH
LEAP THERAPEUTICS, INC.
DDisposition to issuer
Restricted Stock Unitsderivativeindirect: By CoinXit Ltd
+2,411,700$0.00$00Dec 30, 2025
Dec 23, 2025CYPH
LEAP THERAPEUTICS, INC.
AGrant or award
Restricted Stock Unitsderivativeindirect: By CoinXit Ltd
+5,448,157$0.00$05,448,157Dec 30, 2025
Nov 11, 2025CYPH
LEAP THERAPEUTICS, INC.
AGrant or award
Restricted Stock Unitsderivative
+74,700$0.00$074,700Nov 13, 2025
Nov 11, 2025CYPH
LEAP THERAPEUTICS, INC.
AGrant or award
Restricted Stock Unitsderivativeindirect: By CoinXit Ltd
+2,411,700$0.00$02,411,700Nov 13, 2025

Questions about Khing Djien Oei

Answered from the filings on this page, as of the latest one.

Is Khing Djien Oei buying or selling?

In the last 12 months Khing Djien Oei reported 0 open-market buys worth $0 and 1 open-market sell worth $662k on SEC Form 4; the latest was sold $662k of CYPH on Sep 25, 2026. Grants, option exercises and tax withholding are not counted.

How did Khing Djien Oei's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Khing Djien Oei has 0.

Where does Khing Djien Oei file Form 4?

Khing Djien Oei has filed Form 4 at CYPH (LEAP THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Khing Djien Oei: insider trades and track record | InsiderTell